Illumina
$265.72Change from previous close: −2.91%Absolute change: −$7.96
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $40.12B
- Enterprise value
- $41.48B
- P/E (trailing 12 months)
- 49.5
- Forward P/E
- 43.5
- PEG
- 3.38
- Price/book
- 14.1
- Price/sales
- 8.93
- EV/EBITDA
- 35.9
- EV/revenue
- 9.23
Profitability and growth
- Gross margin
- 67.9%
- Operating margin
- 21.1%
- Net margin
- 18.3%
- ROE
- 32.3%
- ROA
- 8.7%
- Revenue growth (year over year)
- 9.4%
- Earnings growth (year over year)
- -9.4%
Financial health
- Total cash
- $1.17B
- Total debt
- $2.53B
- Debt/equity
- 0.89
- Current ratio
- 1.80
- Quick ratio
- 1.25
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $210.65
- Median price target
- $214.00
- High price target
- $305.00
- Low price target
- $113.00
- Analysts with a price target
- 20
- Consensus
- Buy
- Forward EPS
- $6.10
- EPS estimate, current year
- $5.36
Shares and trading
- Beta
- 1.47
- Average volume
- 2.6M
- Shares outstanding
- 151M
- Float
- 149.78M
- Institutional ownership
- 106.4%
- Insider ownership
- 0.2%
- Short interest (% of float)
- 11.5%
- Short ratio (days)
- 5.52